Stock Analysts

UDR Completes Chelsea Acquisition (EQR) (UDR)

UDR, Inc. ( UDR ), a leading multifamily real estate investment trust (REIT), has recently completed the acquisition of 21 Chelsea – a 210-unit luxury apartment community in New York City, for $138 million. The purchase price included the assumption of a $31 million first mortgage loan secured by the property, which is scheduled to mature in June 2012 and can be pre-paid at par in December 2011 […]

Stock Analysts

GM Trims Truck Output (F) (GM)

General Motors Company ( GM ) decided to trim production for pickup trucks over the next 2 months in order to adjust to the slack demand of the sam e on the back of continued weakness in the housing and construction sectors. The automaker has canceled five scheduled overtime shifts on Saturdays in September and October at its Flint, Michigan plant. […]

Stock Analysts

Earnings Preview: Brown-Forman (BF.B) (DEO) (FO) (STZ)

Brown-Forman Corporation ( BF.B ), one of the world's leading producers and distributors of premium alcoholic beverages, is scheduled to report its first-quarter 2012 financial results before the market opens on August 31, 2011. The current Zacks Consensus Estimates for the quarter is earnings of 83 cents a share. For the quarter under review, revenue is expected at $769.0 million, according to the Zacks Consensus Estimate […]

Stock Analysts

Earnings Scorecard: CACI (CACI)

CACI International Inc. ( CACI ) reported earnings of $1.28 per share in the fourth quarter of fiscal 2011, beating the Zacks Consensus Estimate of $1.17. The company noted that the solid results were due to its growth strategy, operational excellence, opportunities provided by developing markets and new contract wins. […]

Stock Analysts

FDA Approves Pfizer’s Xalkori (ABT) (PFE)

Pfizer Inc. ( PFE ) recently received a major boost with the US Food and Drug Administration (FDA) granting approval to Xalkori (crizotinib) for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive, as detected by an FDA-approved test. […]